Tuesday, September 8, 2026, 2:00 pm EDT
For many female patients, suicidal thoughts and attempts follow the hormone shifts of the menstrual cycle. The cause is not abnormal hormone levels, but how sensitive the brain is to normal hormone change. Dr. Eisenlohr-Moul will discuss results of double-blind clinical trials conducted by her team demonstrating that stabilizing hormone changes can prevent these monthly spikes in suicidal thinking for some patients and has identified early biomarkers that could one day help us identify those who might benefit from cycle-focused treatment.
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Sign up for other upcoming webinars.
View past webinar recordings.
Presented by
Tory Anne Eisenlohr-Moul, Ph.D.
Professor, Department of Psychiatry & Behavioral Neuroscience
The University of Chicago
2018 Young Investigator Grant
Tory Eisenlohr-Moul, PhD, is a Professor of Psychiatry and Behavioral Neuroscience at the University of Chicago and a licensed clinical psychologist. She directs the CLEAR Lab and provides clinical care to patients experiencing menstrual mood disorders. Her research asks why some female patients experience severe emotional changes, suicidal thoughts, and suicide attempts that track the menstrual cycle. Through a series of NIH-funded, double-blind clinical trials (the CLEAR trials), her team has shown that, for some patients, stabilizing hormone fluctuations can prevent menstrual spikes in suicidal thinking. She is a 2018 BBRF Young Investigator Awardee. Her long-term goal is to develop personalized treatments for cyclical mood disorders, matched to each person's hormonal triggers.
Moderated by
Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
